GlobalDeal

Vaccinogen

Biotechnology · Baltimore, United States

vaccinogeninc.com

About Vaccinogen

Vaccinogen is a biotechnology company focused on developing innovative cancer immunotherapies. The company specializes in harnessing the body's immune system to target and destroy cancer cells, with a particular emphasis on personalized medicine. Vaccinogen's lead product candidate, OncoVAX, is designed to treat patients with colorectal cancer by stimulating an immune response against tumor-associated antigens. The company is committed to advancing its clinical programs and expanding its pipeline of therapeutic options for cancer patients. Through rigorous research and development, Vaccinogen aims to improve patient outcomes and contribute to the evolving landscape of cancer treatment.

Company facts

Industry
Biotechnology
Sub-industries
Immunotherapy, Cancer Treatment, Personalized Medicine, Pharmaceutical Development, Clinical Research
Location
Baltimore, United States
Employees
1–10
Revenue (USD)
1–5M
Founded
2010

Products and services

Open Vaccinogen in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →